MENU
+Compare
NVCT
Stock ticker: NASDAQ
AS OF
Aug 29, 04:59 PM (EDT)
Price
$6.54
Change
+$0.02 (+0.31%)
Capitalization
167M

NVCT Nuvectis Pharma Forecast, Technical & Fundamental Analysis

Nuvectis Pharma Inc is a biopharmaceutical company... Show more

NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVCT with price predictions
Aug 28, 2025

NVCT in +13.67% Uptrend, rising for three consecutive days on August 12, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NVCT advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVCT's RSI Indicator exited the oversold zone, of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 20, 2025. You may want to consider a long position or call options on NVCT as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NVCT just turned positive on August 20, 2025. Looking at past instances where NVCT's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

NVCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 38 cases where NVCT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for NVCT moved below the 200-day moving average on August 21, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NVCT entered a downward trend on August 19, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.901) is normal, around the industry mean (19.700). P/E Ratio (0.000) is within average values for comparable stocks, (54.040). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.655). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (303.721).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NVCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVCT is expected to report earnings to fall 16.67% to -25 cents per share on November 11

Nuvectis Pharma NVCT Stock Earnings Reports
Q3'25
Est.
$-0.25
Q2'25
Missed
by $0.05
Q1'25
Beat
by $0.53
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.01
The last earnings report on August 05 showed earnings per share of -30 cents, missing the estimate of -25 cents. With 35.94K shares outstanding, the current market capitalization sits at 167.00M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Bridge Plaza
Phone
+1 201 614-3150
Employees
13
Web
https://www.nuvectis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKTPF0.02N/A
+11.11%
Cruz Battery Metals Corp.
SRRTF10.380.12
+1.22%
SLATE GROCERY REIT
MVLY15.40N/A
N/A
Mission Valley Bancorp
FYGGY2.45N/A
N/A
Fuyao Glass Ind Group Co
TSYHY14.06-0.28
-1.95%
TravelSky Technology Ltd.

NVCT and Stocks

Correlation & Price change

A.I.dvisor tells us that NVCT and PDSB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-1.80%
PDSB - NVCT
32%
Poorly correlated
-3.12%
ADMA - NVCT
31%
Poorly correlated
+0.75%
DARE - NVCT
30%
Poorly correlated
+0.25%
SGMT - NVCT
28%
Poorly correlated
-2.83%
AGIO - NVCT
26%
Poorly correlated
-2.78%
More